307 related articles for article (PubMed ID: 15532079)
1. DNA concentrations in BAL fluid of cystic fibrosis patients with early lung disease: influence of treatment with dornase alpha.
Ratjen F; Paul K; van Koningsbruggen S; Breitenstein S; Rietschel E; Nikolaizik W
Pediatr Pulmonol; 2005 Jan; 39(1):1-4. PubMed ID: 15532079
[TBL] [Abstract][Full Text] [Related]
2. Effect of treatment with dornase alpha on airway inflammation in patients with cystic fibrosis.
Paul K; Rietschel E; Ballmann M; Griese M; Worlitzsch D; Shute J; Chen C; Schink T; Döring G; van Koningsbruggen S; Wahn U; Ratjen F;
Am J Respir Crit Care Med; 2004 Mar; 169(6):719-25. PubMed ID: 14684561
[TBL] [Abstract][Full Text] [Related]
3. A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities.
Quan JM; Tiddens HA; Sy JP; McKenzie SG; Montgomery MD; Robinson PJ; Wohl ME; Konstan MW;
J Pediatr; 2001 Dec; 139(6):813-20. PubMed ID: 11743506
[TBL] [Abstract][Full Text] [Related]
4. Dornase alpha and exhaled NO in cystic fibrosis.
Grasemann H; Lax H; Treseler JW; Colin AA
Pediatr Pulmonol; 2004 Nov; 38(5):379-85. PubMed ID: 15390350
[TBL] [Abstract][Full Text] [Related]
5. Dornase alfa in early cystic fibrosis lung disease.
Robinson PJ
Pediatr Pulmonol; 2002 Sep; 34(3):237-41. PubMed ID: 12203856
[TBL] [Abstract][Full Text] [Related]
6. Effect of inhaled fluticasone propionate on BAL TGF-beta(1) and bFGF concentrations in clinically stable lung transplant recipients.
Zheng L; Walters EH; Wang N; Whitford H; Orsida B; Levvey B; Bailey M; Williams TJ; Snell GI
J Heart Lung Transplant; 2004 Apr; 23(4):446-55. PubMed ID: 15063404
[TBL] [Abstract][Full Text] [Related]
7. Aerosolized dornase alfa (rhDNase) for therapy of cystic fibrosis.
Hodson ME
Am J Respir Crit Care Med; 1995 Mar; 151(3 Pt 2):S70-4. PubMed ID: 7881698
[TBL] [Abstract][Full Text] [Related]
8. Effect of recombinant human DNase on alpha1-proteinase inhibitor function: an experimental approach to the combined clinical use of rhDNase and alpha1-PI in CF patients.
Hansen G; Hoffjan S; Mosler K; Schuster A
Lung; 2001; 179(3):185-94. PubMed ID: 11891608
[TBL] [Abstract][Full Text] [Related]
9. Dornase alfa as postoperative therapy in cystic fibrosis sinonasal disease.
Cimmino M; Nardone M; Cavaliere M; Plantulli A; Sepe A; Esposito V; Mazzarella G; Raia V
Arch Otolaryngol Head Neck Surg; 2005 Dec; 131(12):1097-101. PubMed ID: 16365224
[TBL] [Abstract][Full Text] [Related]
10. Lower airway inflammation in infants with cystic fibrosis detected by newborn screening.
Armstrong DS; Hook SM; Jamsen KM; Nixon GM; Carzino R; Carlin JB; Robertson CF; Grimwood K
Pediatr Pulmonol; 2005 Dec; 40(6):500-10. PubMed ID: 16208679
[TBL] [Abstract][Full Text] [Related]
11. Nasal wash as an alternative to bronchoalveolar lavage in detecting early pulmonary inflammation in children with cystic fibrosis.
Pitrez PM; Brennan S; Turner S; Sly PD
Respirology; 2005 Mar; 10(2):177-82. PubMed ID: 15823182
[TBL] [Abstract][Full Text] [Related]
12. Dornase alfa in the treatment of cystic fibrosis in Europe: a report from the Epidemiologic Registry of Cystic Fibrosis.
Hodson ME; McKenzie S; Harms HK; Koch C; Mastella G; Navarro J; Strandvik B;
Pediatr Pulmonol; 2003 Nov; 36(5):427-32. PubMed ID: 14520726
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of recombinant adeno-associated virus (rAAV) transduction by bronchial secretions from cystic fibrosis patients.
Virella-Lowell I; Poirier A; Chesnut KA; Brantly M; Flotte TR
Gene Ther; 2000 Oct; 7(20):1783-9. PubMed ID: 11083501
[TBL] [Abstract][Full Text] [Related]
14. A crossover, randomized, controlled trial of dornase alfa before versus after physiotherapy in cystic fibrosis.
Fitzgerald DA; Hilton J; Jepson B; Smith L
Pediatrics; 2005 Oct; 116(4):e549-54. PubMed ID: 16147970
[TBL] [Abstract][Full Text] [Related]
15. Distinct patterns of inflammation in the airway lumen and bronchial mucosa of children with cystic fibrosis.
Regamey N; Tsartsali L; Hilliard TN; Fuchs O; Tan HL; Zhu J; Qiu YS; Alton EW; Jeffery PK; Bush A; Davies JC
Thorax; 2012 Feb; 67(2):164-70. PubMed ID: 22008188
[TBL] [Abstract][Full Text] [Related]
16. Dornase alfa: a new option in the management of cystic fibrosis.
Witt DM; Anderson L
Pharmacotherapy; 1996; 16(1):40-8. PubMed ID: 8700791
[TBL] [Abstract][Full Text] [Related]
17. Effect of aerosolized rhDNase (Pulmozyme) on pulmonary colonization in patients with cystic fibrosis.
Frederiksen B; Pressler T; Hansen A; Koch C; Høiby N
Acta Paediatr; 2006 Sep; 95(9):1070-4. PubMed ID: 16938752
[TBL] [Abstract][Full Text] [Related]
18. Long-term clarithromycin in cystic fibrosis: effects on inflammatory markers in BAL and clinical status.
Doğru D; Dalgiç F; Kiper N; Ozçelik U; Yalçin E; Aslan AT; Gürcan N; Saricaoğlu F; Gür D; Karayazgan Y; Firat P
Turk J Pediatr; 2009; 51(5):416-23. PubMed ID: 20112595
[TBL] [Abstract][Full Text] [Related]
19. Neutrophil mediators, Pseudomonas, and pulmonary dysfunction in cystic fibrosis.
Meyer KC; Zimmerman J
J Lab Clin Med; 1993 May; 121(5):654-61. PubMed ID: 8386737
[TBL] [Abstract][Full Text] [Related]
20. NO pathway in CF and non-CF children.
Wooldridge JL; Deutsch GH; Sontag MK; Osberg I; Chase DR; Silkoff PE; Wagener JS; Abman SH; Accurso FJ
Pediatr Pulmonol; 2004 Apr; 37(4):338-50. PubMed ID: 15022131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
